山东全重生物医药科技

Shandong Quanzhong Biopharmaceutical Technology is a pharmaceutical enterprise based in Jinan, China, that specializes in the research, development, and manufacturing of high-end generic drugs and innovative chemical entities. The company operates as a comprehensive service provider, offering Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services for pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Their core therapeutic focus areas include cardiovascular and cerebrovascular diseases, oncology, and anti-infective medicine. Quanzhong Bio leverages advanced synthesis technologies and process optimization to bridge the gap between laboratory research and large-scale industrial production. The company is committed to providing high-quality, cost-effective pharmaceutical solutions through its modern R&D and pilot plant facilities.